These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20852412)

  • 1. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.
    Crowner BE; Torres-Russotto D; Carter AR; Racette BA
    Clin Neuropharmacol; 2010; 33(5):243-7. PubMed ID: 20852412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases.
    Bhatia KP; Münchau A; Thompson PD; Houser M; Chauhan VS; Hutchinson M; Shapira AH; Marsden CD
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):90-3. PubMed ID: 10369829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin.
    Clark GT
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):727-48. PubMed ID: 14580034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of botulinum toxin injections in dystonia.
    Ramirez-Castaneda J; Jankovic J
    Toxins (Basel); 2013 Feb; 5(2):249-66. PubMed ID: 23381141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of laryngeal dystonia with botulinum toxin].
    Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.
    Müller J; Wenning GK; Wissel J; Seppi K; Poewe W
    J Neurol; 2002 Mar; 249(3):300-4. PubMed ID: 11993530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible adverse effects of intramuscular botulinum toxin injections and their management.
    Bakheit AM
    Curr Drug Saf; 2006 Aug; 1(3):271-9. PubMed ID: 18690938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin therapy for cervical dystonia.
    Walker FO
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
    Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
    J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of botulinum toxin in head and neck disorders.
    Hawthorne MR
    Hosp Med; 2003 Aug; 64(8):460-3. PubMed ID: 12958756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin.
    Childers MK
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):781-92. PubMed ID: 14580037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
    Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
    Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dose-response relationship in the treatment of cervical dystonia with botulinum toxin type A (AGN 191622)--a phase II study].
    Mezaki T; Kaji R; Kimura J; Mannen T
    No To Shinkei; 1995 Sep; 47(9):857-62. PubMed ID: 7546934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate response to botulinum toxin injections in patients with fixed dystonia.
    Edwards MJ; Bhatia KP; Cordivari C
    Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity.
    Varghese-Kroll E; Elovic EP
    Am J Phys Med Rehabil; 2009 Jun; 88(6):495-9. PubMed ID: 19454855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injections for cervical dystonia.
    Jankovic J; Schwartz K
    Neurology; 1990 Feb; 40(2):277-80. PubMed ID: 2300249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.